ID-Cap System
Commercial- Indications
- Medication adherence monitoring
Company intelligence / Profile preview
The ID-Cap System by etectRx has FDA clearance as an ingestible event marker to monitor oral medication adherence. It has been validated in over ten clinical studies with more than ten thousand monitored ingestions. The system demonstrates high accuracy (~98% when used correctly) and supports remote patient engagement across various therapeutic areas including mental health and infectious diseases. Recent studies include successful pilots for PrEP adherence and ongoing expansion into new indications such as tuberculosis and incontinence monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on etectRx.